Balimbingan, Lita .
HRN: 16-72-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFTRIAXONE 1G (VIAL)
03/19/2025
03/26/2025
IVT
2 Gm
OD
T/c Partial Mechanical Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes